(600267)"Zhejiang Hisun Pharmaceutical Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 600267 · · 14 pages · Chinese
Summary by 6ix AI
The report indicates significant changes in financial metrics, including revenue and net profit figures compared to the same period last year. It also discusses the company's plans for establishing a wholly-owned subsidiary in Hong Kong and other operational updates. The financial statements included in the report are unaudited, and the company assures the accuracy and completeness of the information provided.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Zhejiang Hisun Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Hisun Pharmaceutical
- (600267)"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on Abnormal Fluctuations in Stock Trading
- (600267)"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on Operating Data for the First Three Quarters of 2026
- (600267)"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on Completion of the Industrial and Commercial Registration Change and Issuance of a New Business License
- (600267)"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on Obtaining the Approval for Veterinary Drug Product Approval Number by Subsidiary
- Indicative Announcement on Results of the Agreement-based Transfer of the Company's Shares by Shareholder Holding More Than 5% of the Shares through Public Solicitation and Signing of the Share Transfer Agreement with the Transferee
Later from Zhejiang Hisun Pharmaceutical
- (600267)"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing
- (600267)"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on Completion of Registration of Share Transfer under Agreement by Shareholder Holding More Than 5% of the Shares
- (600267)"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on Departure of a Director
- (600267)"Zhejiang Hisun Pharmaceutical Co., Ltd."Indicative Announcement on Convening the 4th Extraordinary General Meeting in 2026
Follow Zhejiang Hisun Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Hisun Pharmaceutical